Optimizerx CORP (OPRX) — 8-K Filings

8-K Filings (20)

• OptimizeRx Corp Files 8-K on Financials — Nov 6, 2025 Risk: low
  OptimizeRx Corp filed an 8-K on November 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and e
• OptimizeRx Corp. Announces Board and Executive Changes — Aug 19, 2025 Risk: medium
  OptimizeRx Corp. announced on August 15, 2025, changes related to its board of directors and executive compensation. The filing indicates a departure of directo
• OptimizeRx Corp Files 8-K on Financials — Aug 7, 2025 Risk: low
  OptimizeRx Corp filed an 8-K on August 7, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exh
• OptimizeRx Corp. Files 8-K: Director & Officer Changes — Jun 24, 2025 Risk: medium
  OptimizeRx Corp. announced on June 20, 2025, changes related to its board of directors and executive compensation. The filing details the departure of certain o
• OptimizeRx Corp. Submits Matters for Security Holder Vote — Jun 16, 2025 Risk: low
  OptimizeRx Corp. announced on June 11, 2025, that it is submitting matters to a vote of its security holders. The filing does not specify the nature of the vote
• OptimizeRx Corp Files 8-K on Financials — May 12, 2025 Risk: low
  OptimizeRx Corp filed an 8-K on May 12, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhib
• OptimizeRx to Acquire Caregility Corp. — Apr 18, 2025 Risk: medium
  OptimizeRx Corp announced on April 18, 2025, that it has entered into a definitive agreement to acquire Caregility Corp. The transaction is expected to close in
• OptimizeRx Corp Files 8-K on Financials — Mar 12, 2025 Risk: low
  OptimizeRx Corp filed an 8-K on March 12, 2025, reporting on its financial condition and operations. The filing includes financial statements and exhibits relat
• OptimizeRx Corp. Announces Board and Executive Changes — Mar 10, 2025 Risk: medium
  OptimizeRx Corp. announced on March 10, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of cer
• OptimizeRx Corp Announces Board and Executive Changes — Jan 10, 2025 Risk: medium
  OptimizeRx Corp announced on January 3, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of cer
• OptimizeRx Corp Elects New Directors, Discloses Officer Compensation — Dec 23, 2024 Risk: medium
  OptimizeRx Corp announced on December 19, 2024, a change in its board of directors, with the election of two new directors, Dr. David J. Shulkin and Mr. David R
• OptimizeRx Corp. Files 8-K on Financials — Nov 13, 2024 Risk: low
  OptimizeRx Corp. filed an 8-K on November 13, 2024, reporting on its results of operations and financial condition, and filing financial statements and exhibits
• OptimizeRx to Acquire PatientPoint for $1.1B — Aug 8, 2024 Risk: medium
  OptimizeRx Corp. announced on August 8, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of PatientPoint Group Holdings,
• OptimizeRx Corp. Announces Director Changes, CFO Appointment, Stock Split — Jun 7, 2024 Risk: medium
  OptimizeRx Corp. announced on June 5, 2024, a series of significant corporate actions. These include the departure of director Michael A. DeSimone, the election
• OptimizeRx Corp. Files 8-K on Financials — May 14, 2024 Risk: low
  OptimizeRx Corp. filed an 8-K on May 14, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
• OptimizeRx to Acquire Caregility for $113M — Apr 29, 2024 Risk: medium
  OptimizeRx Corp. announced on April 26, 2024, that it has entered into a definitive agreement to acquire Caregility Corp. for an enterprise value of approximate
• OptimizeRx to Acquire PatientPoint Group Holdings — Apr 18, 2024 Risk: medium
  OptimizeRx Corp announced on April 16, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of PatientPoint Group Holdings, L
• OptimizeRx Corp Files 8-K for Material Agreement — Apr 2, 2024 Risk: medium
  OptimizeRx Corporation announced a material definitive agreement on March 28, 2024. The company, incorporated in Nevada, filed its 8-K report on April 2, 2024,
• OptimizeRx to Acquire Caregility for $120M — Mar 11, 2024 Risk: medium
  OptimizeRx Corp announced on March 11, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of Caregility Corp. for an aggreg
• OptimizeRx 8-K: Executive Compensation & Officer Changes — Jan 26, 2024
  OptimizeRx Corporation filed an 8-K on January 26, 2024, reporting an event that occurred on January 24, 2024. This filing primarily concerns changes in executi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX